Monlunabant

Overview

Monlunabant ((S)-MRI-1891) is an orally active antagonist for cannabinoid receptor 1 ( CB1 ), binds to hCB1 and hCB2 with K i of 0.3 nM and 613 nM.

Application

Products | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Pain | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Cannabinoid Receptor | Products > Signaling Pathways > Arrestin

Product Information

• Catalog No.: HY-153800
• CAS No.: 2712480-46-9
• Molecular Formula: C26H22ClF3N6O3S
• Molecular Weight: 591.00
• Purity: 99.99%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (4.23 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source